Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

Yeming Wang, Fei Zhou, Dingyu Zhang, Jianping Zhao, Ronghui Du, Yi Hu, Zhenshun Cheng, Ling Gao, Yang Jin, Guangwei Luo, Shouzhi Fu, Qiaofa Lu, Guanhua Du, Ke Wang, Yang Lu, Guohui Fan, Yi Zhang, Ying Liu, Shunan Ruan, Wen Liu, Thomas Jaki, Frederick G. Hayden, Peter W. Horby, Bin Cao, Chen Wang

Open source

DOI: 10.1186/s13063-020-04352-9
Published: 2020-05-24
Container: Trials
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13063-020-04352-9,
  title = {Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial},
  author = {Yeming Wang and Fei Zhou and Dingyu Zhang and Jianping Zhao and Ronghui Du and Yi Hu and Zhenshun Cheng and Ling Gao and Yang Jin and Guangwei Luo and Shouzhi Fu and Qiaofa Lu and Guanhua Du and Ke Wang and Yang Lu and Guohui Fan and Yi Zhang and Ying Liu and Shunan Ruan and Wen Liu and Thomas Jaki and Frederick G. Hayden and Peter W. Horby and Bin Cao and Chen Wang},
  year = {2020},
  journal = {Trials},
  doi = {10.1186/s13063-020-04352-9},
  url = {https://doi.org/10.1186/s13063-020-04352-9}
}

RIS

TY  - JOUR
TI  - Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial
AU  - Yeming Wang
AU  - Fei Zhou
AU  - Dingyu Zhang
AU  - Jianping Zhao
AU  - Ronghui Du
AU  - Yi Hu
AU  - Zhenshun Cheng
AU  - Ling Gao
AU  - Yang Jin
AU  - Guangwei Luo
AU  - Shouzhi Fu
AU  - Qiaofa Lu
AU  - Guanhua Du
AU  - Ke Wang
AU  - Yang Lu
AU  - Guohui Fan
AU  - Yi Zhang
AU  - Ying Liu
AU  - Shunan Ruan
AU  - Wen Liu
AU  - Thomas Jaki
AU  - Frederick G. Hayden
AU  - Peter W. Horby
AU  - Bin Cao
AU  - Chen Wang
PY  - 2020
JO  - Trials
DO  - 10.1186/s13063-020-04352-9
UR  - https://doi.org/10.1186/s13063-020-04352-9
ER  -

APA

Wang, Y., Zhou, F., Zhang, D., Zhao, J., Du, R., Hu, Y., Cheng, Z., Gao, L., Jin, Y., Luo, G., Fu, S., Lu, Q., Du, G., Wang, K., Lu, Y., Fan, G., Zhang, Y., Liu, Y., Ruan, S., Liu, W., Jaki, T., Hayden, F. G., Horby, P. W., Cao, B., & Wang, C. (2020). Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. https://doi.org/10.1186/s13063-020-04352-9

Source records

crossref · retrieved 2026-11-05T09:22:47.391Z